Clinical Trial

Biomarkers in Prediction of AMI

Study acronym: BIPAMI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-15.
Status change: Not Yet Recruiting → Recruiting 2024-11-27
Trial Details
NCT Number NCT06212921
Lead Sponsor University of Tartu
Conditions Acute Mesenteric Ischemia
Enrollment 250 participants
Start Date 2024-10-14
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-03